XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statement of Earnings (Unaudited) - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net sales $ 11,369 $ 10,635 $ 32,869 $ 30,976
Cost of products sold, excluding amortization of intangible assets 5,075 4,698 14,397 13,764
Amortization of intangible assets 420 470 1,260 1,413
Research and development 766 713 2,207 2,095
Selling, general and administrative 3,051 2,895 9,203 8,790
Total operating cost and expenses 9,312 8,776 27,067 26,062
Operating earnings 2,057 1,859 5,802 4,914
Interest expense 121 142 373 423
Interest (income) (77) (91) (230) (253)
Net foreign exchange (gain) loss (17) (11) (35) (17)
Other (income) expense, net (150) (121) (414) (222)
Earnings before taxes 2,180 1,940 6,108 4,983
Taxes on earnings 536 294 1,360 810
Net Earnings $ 1,644 $ 1,646 $ 4,748 $ 4,173
Basic Earnings Per Common Share (in dollars per share) $ 0.94 $ 0.94 $ 2.72 $ 2.39
Diluted Earnings Per Common Share (in dollars per share) $ 0.94 $ 0.94 $ 2.70 $ 2.38
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) 1,742,142 1,739,466 1,741,617 1,740,869
Dilutive Common Stock Options (in shares) 7,219 8,131 7,544 8,565
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares) 1,749,361 1,747,597 1,749,161 1,749,434
Outstanding Common Stock Options Having No Dilutive Effect (in shares) 1,443 6,905 1,431 6,892